Whether KRT13 is simply a biomarker of a stem-like state that is associated with aggressive disease or actually plays a functional role in metastatic progression of prostate cancer remains to be determined, as is further validation of KRT13 as a potential prognostic biomarker for aggressive prostate cancer. The gene discussed is KRT13; the disease is prostate cancer.